Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
This comparison of outcomes of allogeneic hematopoietic stem-cell transplantation in 1993–1997 and 2003–2007 shows that although patients had a somewhat poorer overall prognosis in the more recent period, the rate of death not preceded by relapse, the risk of relapse, and overall mortality decreased...
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2010-11, Vol.363 (22), p.2091-2101 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2101 |
|---|---|
| container_issue | 22 |
| container_start_page | 2091 |
| container_title | The New England journal of medicine |
| container_volume | 363 |
| creator | Gooley, Ted A Chien, Jason W Pergam, Steven A Hingorani, Sangeeta Sorror, Mohamed L Boeckh, Michael Martin, Paul J Sandmaier, Brenda M Marr, Kieren A Appelbaum, Frederick R Storb, Rainer McDonald, George B |
| description | This comparison of outcomes of allogeneic hematopoietic stem-cell transplantation in 1993–1997 and 2003–2007 shows that although patients had a somewhat poorer overall prognosis in the more recent period, the rate of death not preceded by relapse, the risk of relapse, and overall mortality decreased.
Infections, graft-versus-host disease (GVHD), and liver, kidney, and pulmonary complications have been associated with high mortality after allogeneic hematopoietic-cell transplantation since the introduction of this procedure 40 years ago.
1
Changes in practice have decreased organ toxicity,
2
–
5
and improved prevention and treatment strategies have decreased the severity of acute GVHD.
6
–
9
The control of infectious complications has improved since the development of molecular methods for the detection of viral and fungal infections, the use of preemptive treatments, the introduction of new antifungal agents, and the prevention of nosocomial infection.
10
–
13
To examine the hypothesis that changes in the care of . . . |
| doi_str_mv | 10.1056/NEJMoa1004383 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3017343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>814463507</sourcerecordid><originalsourceid>FETCH-LOGICAL-c583t-b2254e719c245cb9c215b3ee158fc5bd2320dd9bc897c289a7ade9b7b8aa50123</originalsourceid><addsrcrecordid>eNp1kc9rFDEUx4NY7LZ69CqDUHqamp-TzEUoy2qVVkHqOWQyb2qWTLImGaH_vSldWyuYyzvkk0_ee1-EXhN8RrDo3n3ZfL6KhmDMmWLP0IoIxlrOcfccrTCmquWyZ4foKOctrofw_gU6pKS-lT1Zoc03GBcLY3MVUzHeldvGTAVSc-59vIEAzjYXMJsSd9FBcbZdg_fNdTIh77wJxRQXw0t0MBmf4dW-HqPvHzbX64v28uvHT-vzy9YKxUo7UCo4SNJbyoUdaiFiYABEqMmKYaSM4nHsB6t6aanqjTQj9IMclDECE8qO0ft7724ZZhgthJKM17vkZpNudTROP70J7oe-ib80w0QyzqrgdC9I8ecCuejZZVsnMgHikrUinHdMYFnJt_-Q27ikUKerUNUxgu907T1kU8w5wfTQCsH6Lh79JJ7Kv_m7_wf6Tx4VONkDJlvjp7pm6_Ijx3jHOyUfuXnOOsB2_s-HvwGXVaP7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>813013103</pqid></control><display><type>article</type><title>Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><source>New England Journal of Medicine</source><creator>Gooley, Ted A ; Chien, Jason W ; Pergam, Steven A ; Hingorani, Sangeeta ; Sorror, Mohamed L ; Boeckh, Michael ; Martin, Paul J ; Sandmaier, Brenda M ; Marr, Kieren A ; Appelbaum, Frederick R ; Storb, Rainer ; McDonald, George B</creator><creatorcontrib>Gooley, Ted A ; Chien, Jason W ; Pergam, Steven A ; Hingorani, Sangeeta ; Sorror, Mohamed L ; Boeckh, Michael ; Martin, Paul J ; Sandmaier, Brenda M ; Marr, Kieren A ; Appelbaum, Frederick R ; Storb, Rainer ; McDonald, George B</creatorcontrib><description>This comparison of outcomes of allogeneic hematopoietic stem-cell transplantation in 1993–1997 and 2003–2007 shows that although patients had a somewhat poorer overall prognosis in the more recent period, the rate of death not preceded by relapse, the risk of relapse, and overall mortality decreased.
Infections, graft-versus-host disease (GVHD), and liver, kidney, and pulmonary complications have been associated with high mortality after allogeneic hematopoietic-cell transplantation since the introduction of this procedure 40 years ago.
1
Changes in practice have decreased organ toxicity,
2
–
5
and improved prevention and treatment strategies have decreased the severity of acute GVHD.
6
–
9
The control of infectious complications has improved since the development of molecular methods for the detection of viral and fungal infections, the use of preemptive treatments, the introduction of new antifungal agents, and the prevention of nosocomial infection.
10
–
13
To examine the hypothesis that changes in the care of . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa1004383</identifier><identifier>PMID: 21105791</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Waltham, MA: Massachusetts Medical Society</publisher><subject>Adolescent ; Adult ; Aged ; Bilirubin - blood ; Biological and medical sciences ; Bone Marrow Diseases - mortality ; Bone Marrow Diseases - therapy ; Child ; Child, Preschool ; Creatinine - blood ; Cytomegalovirus ; Drug dosages ; Epidemiology ; Fungal infections ; General aspects ; Graft vs Host Disease - epidemiology ; Graft vs Host Disease - mortality ; Hematopoietic Stem Cell Transplantation - adverse effects ; Hematopoietic Stem Cell Transplantation - mortality ; Humans ; Infant ; Infection - epidemiology ; Infection - etiology ; Kidney Diseases - epidemiology ; Kidney Diseases - etiology ; Leukemia - mortality ; Leukemia - therapy ; Liver Diseases - epidemiology ; Liver Diseases - etiology ; Lung Diseases - epidemiology ; Lung Diseases - etiology ; Lymphoma, Non-Hodgkin - mortality ; Lymphoma, Non-Hodgkin - therapy ; Medical sciences ; Middle Aged ; Mortality ; Mortality - trends ; Multiple Myeloma - mortality ; Multiple Myeloma - therapy ; Myelodysplastic Syndromes - therapy ; Nosocomial infections ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Recurrence ; Transplantation, Homologous - mortality ; Transplants & implants ; Young Adult</subject><ispartof>The New England journal of medicine, 2010-11, Vol.363 (22), p.2091-2101</ispartof><rights>Copyright © 2010 Massachusetts Medical Society. All rights reserved.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c583t-b2254e719c245cb9c215b3ee158fc5bd2320dd9bc897c289a7ade9b7b8aa50123</citedby><cites>FETCH-LOGICAL-c583t-b2254e719c245cb9c215b3ee158fc5bd2320dd9bc897c289a7ade9b7b8aa50123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa1004383$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMoa1004383$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>230,314,776,780,881,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23464687$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21105791$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gooley, Ted A</creatorcontrib><creatorcontrib>Chien, Jason W</creatorcontrib><creatorcontrib>Pergam, Steven A</creatorcontrib><creatorcontrib>Hingorani, Sangeeta</creatorcontrib><creatorcontrib>Sorror, Mohamed L</creatorcontrib><creatorcontrib>Boeckh, Michael</creatorcontrib><creatorcontrib>Martin, Paul J</creatorcontrib><creatorcontrib>Sandmaier, Brenda M</creatorcontrib><creatorcontrib>Marr, Kieren A</creatorcontrib><creatorcontrib>Appelbaum, Frederick R</creatorcontrib><creatorcontrib>Storb, Rainer</creatorcontrib><creatorcontrib>McDonald, George B</creatorcontrib><title>Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>This comparison of outcomes of allogeneic hematopoietic stem-cell transplantation in 1993–1997 and 2003–2007 shows that although patients had a somewhat poorer overall prognosis in the more recent period, the rate of death not preceded by relapse, the risk of relapse, and overall mortality decreased.
Infections, graft-versus-host disease (GVHD), and liver, kidney, and pulmonary complications have been associated with high mortality after allogeneic hematopoietic-cell transplantation since the introduction of this procedure 40 years ago.
1
Changes in practice have decreased organ toxicity,
2
–
5
and improved prevention and treatment strategies have decreased the severity of acute GVHD.
6
–
9
The control of infectious complications has improved since the development of molecular methods for the detection of viral and fungal infections, the use of preemptive treatments, the introduction of new antifungal agents, and the prevention of nosocomial infection.
10
–
13
To examine the hypothesis that changes in the care of . . .</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Bilirubin - blood</subject><subject>Biological and medical sciences</subject><subject>Bone Marrow Diseases - mortality</subject><subject>Bone Marrow Diseases - therapy</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Creatinine - blood</subject><subject>Cytomegalovirus</subject><subject>Drug dosages</subject><subject>Epidemiology</subject><subject>Fungal infections</subject><subject>General aspects</subject><subject>Graft vs Host Disease - epidemiology</subject><subject>Graft vs Host Disease - mortality</subject><subject>Hematopoietic Stem Cell Transplantation - adverse effects</subject><subject>Hematopoietic Stem Cell Transplantation - mortality</subject><subject>Humans</subject><subject>Infant</subject><subject>Infection - epidemiology</subject><subject>Infection - etiology</subject><subject>Kidney Diseases - epidemiology</subject><subject>Kidney Diseases - etiology</subject><subject>Leukemia - mortality</subject><subject>Leukemia - therapy</subject><subject>Liver Diseases - epidemiology</subject><subject>Liver Diseases - etiology</subject><subject>Lung Diseases - epidemiology</subject><subject>Lung Diseases - etiology</subject><subject>Lymphoma, Non-Hodgkin - mortality</subject><subject>Lymphoma, Non-Hodgkin - therapy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Mortality - trends</subject><subject>Multiple Myeloma - mortality</subject><subject>Multiple Myeloma - therapy</subject><subject>Myelodysplastic Syndromes - therapy</subject><subject>Nosocomial infections</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Recurrence</subject><subject>Transplantation, Homologous - mortality</subject><subject>Transplants & implants</subject><subject>Young Adult</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kc9rFDEUx4NY7LZ69CqDUHqamp-TzEUoy2qVVkHqOWQyb2qWTLImGaH_vSldWyuYyzvkk0_ee1-EXhN8RrDo3n3ZfL6KhmDMmWLP0IoIxlrOcfccrTCmquWyZ4foKOctrofw_gU6pKS-lT1Zoc03GBcLY3MVUzHeldvGTAVSc-59vIEAzjYXMJsSd9FBcbZdg_fNdTIh77wJxRQXw0t0MBmf4dW-HqPvHzbX64v28uvHT-vzy9YKxUo7UCo4SNJbyoUdaiFiYABEqMmKYaSM4nHsB6t6aanqjTQj9IMclDECE8qO0ft7724ZZhgthJKM17vkZpNudTROP70J7oe-ib80w0QyzqrgdC9I8ecCuejZZVsnMgHikrUinHdMYFnJt_-Q27ikUKerUNUxgu907T1kU8w5wfTQCsH6Lh79JJ7Kv_m7_wf6Tx4VONkDJlvjp7pm6_Ijx3jHOyUfuXnOOsB2_s-HvwGXVaP7</recordid><startdate>20101125</startdate><enddate>20101125</enddate><creator>Gooley, Ted A</creator><creator>Chien, Jason W</creator><creator>Pergam, Steven A</creator><creator>Hingorani, Sangeeta</creator><creator>Sorror, Mohamed L</creator><creator>Boeckh, Michael</creator><creator>Martin, Paul J</creator><creator>Sandmaier, Brenda M</creator><creator>Marr, Kieren A</creator><creator>Appelbaum, Frederick R</creator><creator>Storb, Rainer</creator><creator>McDonald, George B</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20101125</creationdate><title>Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation</title><author>Gooley, Ted A ; Chien, Jason W ; Pergam, Steven A ; Hingorani, Sangeeta ; Sorror, Mohamed L ; Boeckh, Michael ; Martin, Paul J ; Sandmaier, Brenda M ; Marr, Kieren A ; Appelbaum, Frederick R ; Storb, Rainer ; McDonald, George B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c583t-b2254e719c245cb9c215b3ee158fc5bd2320dd9bc897c289a7ade9b7b8aa50123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Bilirubin - blood</topic><topic>Biological and medical sciences</topic><topic>Bone Marrow Diseases - mortality</topic><topic>Bone Marrow Diseases - therapy</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Creatinine - blood</topic><topic>Cytomegalovirus</topic><topic>Drug dosages</topic><topic>Epidemiology</topic><topic>Fungal infections</topic><topic>General aspects</topic><topic>Graft vs Host Disease - epidemiology</topic><topic>Graft vs Host Disease - mortality</topic><topic>Hematopoietic Stem Cell Transplantation - adverse effects</topic><topic>Hematopoietic Stem Cell Transplantation - mortality</topic><topic>Humans</topic><topic>Infant</topic><topic>Infection - epidemiology</topic><topic>Infection - etiology</topic><topic>Kidney Diseases - epidemiology</topic><topic>Kidney Diseases - etiology</topic><topic>Leukemia - mortality</topic><topic>Leukemia - therapy</topic><topic>Liver Diseases - epidemiology</topic><topic>Liver Diseases - etiology</topic><topic>Lung Diseases - epidemiology</topic><topic>Lung Diseases - etiology</topic><topic>Lymphoma, Non-Hodgkin - mortality</topic><topic>Lymphoma, Non-Hodgkin - therapy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Mortality - trends</topic><topic>Multiple Myeloma - mortality</topic><topic>Multiple Myeloma - therapy</topic><topic>Myelodysplastic Syndromes - therapy</topic><topic>Nosocomial infections</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Recurrence</topic><topic>Transplantation, Homologous - mortality</topic><topic>Transplants & implants</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gooley, Ted A</creatorcontrib><creatorcontrib>Chien, Jason W</creatorcontrib><creatorcontrib>Pergam, Steven A</creatorcontrib><creatorcontrib>Hingorani, Sangeeta</creatorcontrib><creatorcontrib>Sorror, Mohamed L</creatorcontrib><creatorcontrib>Boeckh, Michael</creatorcontrib><creatorcontrib>Martin, Paul J</creatorcontrib><creatorcontrib>Sandmaier, Brenda M</creatorcontrib><creatorcontrib>Marr, Kieren A</creatorcontrib><creatorcontrib>Appelbaum, Frederick R</creatorcontrib><creatorcontrib>Storb, Rainer</creatorcontrib><creatorcontrib>McDonald, George B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>Biological Sciences</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gooley, Ted A</au><au>Chien, Jason W</au><au>Pergam, Steven A</au><au>Hingorani, Sangeeta</au><au>Sorror, Mohamed L</au><au>Boeckh, Michael</au><au>Martin, Paul J</au><au>Sandmaier, Brenda M</au><au>Marr, Kieren A</au><au>Appelbaum, Frederick R</au><au>Storb, Rainer</au><au>McDonald, George B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2010-11-25</date><risdate>2010</risdate><volume>363</volume><issue>22</issue><spage>2091</spage><epage>2101</epage><pages>2091-2101</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>This comparison of outcomes of allogeneic hematopoietic stem-cell transplantation in 1993–1997 and 2003–2007 shows that although patients had a somewhat poorer overall prognosis in the more recent period, the rate of death not preceded by relapse, the risk of relapse, and overall mortality decreased.
Infections, graft-versus-host disease (GVHD), and liver, kidney, and pulmonary complications have been associated with high mortality after allogeneic hematopoietic-cell transplantation since the introduction of this procedure 40 years ago.
1
Changes in practice have decreased organ toxicity,
2
–
5
and improved prevention and treatment strategies have decreased the severity of acute GVHD.
6
–
9
The control of infectious complications has improved since the development of molecular methods for the detection of viral and fungal infections, the use of preemptive treatments, the introduction of new antifungal agents, and the prevention of nosocomial infection.
10
–
13
To examine the hypothesis that changes in the care of . . .</abstract><cop>Waltham, MA</cop><pub>Massachusetts Medical Society</pub><pmid>21105791</pmid><doi>10.1056/NEJMoa1004383</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2010-11, Vol.363 (22), p.2091-2101 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3017343 |
| source | MEDLINE; EZB Electronic Journals Library; New England Journal of Medicine |
| subjects | Adolescent Adult Aged Bilirubin - blood Biological and medical sciences Bone Marrow Diseases - mortality Bone Marrow Diseases - therapy Child Child, Preschool Creatinine - blood Cytomegalovirus Drug dosages Epidemiology Fungal infections General aspects Graft vs Host Disease - epidemiology Graft vs Host Disease - mortality Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - mortality Humans Infant Infection - epidemiology Infection - etiology Kidney Diseases - epidemiology Kidney Diseases - etiology Leukemia - mortality Leukemia - therapy Liver Diseases - epidemiology Liver Diseases - etiology Lung Diseases - epidemiology Lung Diseases - etiology Lymphoma, Non-Hodgkin - mortality Lymphoma, Non-Hodgkin - therapy Medical sciences Middle Aged Mortality Mortality - trends Multiple Myeloma - mortality Multiple Myeloma - therapy Myelodysplastic Syndromes - therapy Nosocomial infections Public health. Hygiene Public health. Hygiene-occupational medicine Recurrence Transplantation, Homologous - mortality Transplants & implants Young Adult |
| title | Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T15%3A51%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20Mortality%20after%20Allogeneic%20Hematopoietic-Cell%20Transplantation&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Gooley,%20Ted%20A&rft.date=2010-11-25&rft.volume=363&rft.issue=22&rft.spage=2091&rft.epage=2101&rft.pages=2091-2101&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJMoa1004383&rft_dat=%3Cproquest_pubme%3E814463507%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=813013103&rft_id=info:pmid/21105791&rfr_iscdi=true |